Mini appoints David Endicott and Linnea Burman to its board

Mini appointed David Endicott and Linnea Burman to its Board of Directors, effective June 29, 2026.Original SEC Filing: MiniMed Group, Inc. [ MMED ] - 8-K - Jun. 29, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note…

Mini appointed David Endicott and Linnea Burman to its Board of Directors, effective June 29, 2026.

IndividualDavid EndicottLinnea Burman

RoleDirector; will serve as Class I director; member of Compensation and Talent CommitteeDirector

Type of ChangeAppointedAppointed

Effective DateJune 29, 2026June 29, 2026

ReasonBoard increased size from nine to 11 and filled resulting vacancyBoard increased size from nine to 11 and filled resulting vacancy

Replacement InfoNot disclosedNot disclosed

Background DetailsCEO of Alcon; Alcon board member since 2019; prior senior leadership at Alcon Laboratories, Hospira and Allergan; MBA USC; BA Chemistry Whitman CollegeNot disclosed

Board/Committee Role ChangesMember of Compensation and Talent CommitteeNot disclosed

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.